Montreal, Canada · Founded 2021 · Acquired/Merged (Operating Subsidiary)
Operator of a biopharmaceutical company intended for pulmonary hypertension and musculoskeletal disorders. 35Pharma is based in Montreal, Canada and was founded in 2021. Its last known valuation is $950 million (Apr 2026). It has raised $70 million.
Last price · $/share
—
Implied valuation
$950.0M
Total raised
$70.0M
Last round
—
Cap table — not yet on record
35Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 35Pharma with a free account
·Watch 35Pharma: the Monday email on marks, rounds and moves
